BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17914110)

  • 1. A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.
    Fujarewicz K; Jarzab M; Eszlinger M; Krohn K; Paschke R; Oczko-Wojciechowska M; Wiench M; Kukulska A; Jarzab B; Swierniak A
    Endocr Relat Cancer; 2007 Sep; 14(3):809-26. PubMed ID: 17914110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
    Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
    Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
    Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups.
    Eszlinger M; Wiench M; Jarzab B; Krohn K; Beck M; Läuter J; Gubała E; Fujarewicz K; Swierniak A; Paschke R
    J Clin Endocrinol Metab; 2006 May; 91(5):1934-42. PubMed ID: 16407496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomas.
    Hamada A; Mankovskaya S; Saenko V; Rogounovitch T; Mine M; Namba H; Nakashima M; Demidchik Y; Demidchik E; Yamashita S
    Cancer Lett; 2005 Jun; 224(2):289-301. PubMed ID: 15914279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
    Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.
    Vierlinger K; Mansfeld MH; Koperek O; Nöhammer C; Kaserer K; Leisch F
    BMC Med Genomics; 2011 Apr; 4():30. PubMed ID: 21470421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
    Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
    Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of four genes accurately differentiates benign from malignant thyroid nodules.
    Wang QX; Chen ED; Cai YF; Li Q; Jin YX; Jin WX; Wang YH; Zheng ZC; Xue L; Wang OC; Zhang XH
    J Exp Clin Cancer Res; 2016 Oct; 35(1):169. PubMed ID: 27793213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.
    Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F
    Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene expression analysis by DNA microarray in papillary thyroid cancer].
    Gubała E; Wiench M; Oczko-Wojciechowska M; Lange D; Włoch J; Czarniecka A; Chmielik E; Nikiel B; Wygoda Z; Kukulska A; Handkiewicz-Junak D; Szpak-Ulczok S; Krawczyk A; Roskosz J; Jarzab B
    Endokrynol Pol; 2005; 56(5):752-7. PubMed ID: 16817140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers.
    Port M; Boltze C; Wang Y; Röper B; Meineke V; Abend M
    Radiat Res; 2007 Dec; 168(6):639-49. PubMed ID: 18088181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors.
    Ory C; Ugolin N; Levalois C; Lacroix L; Caillou B; Bidart JM; Schlumberger M; Diallo I; de Vathaire F; Hofman P; Santini J; Malfoy B; Chevillard S
    Endocr Relat Cancer; 2011 Feb; 18(1):193-206. PubMed ID: 21148326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.
    Domingues R; Mendonça E; Sobrinho L; Bugalho MJ
    Cytopathology; 2005 Feb; 16(1):27-31. PubMed ID: 15859312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth.
    Johnson DN; Furtado LV; Long BC; Zhen CJ; Wurst M; Mujacic I; Kadri S; Segal JP; Antic T; Cipriani NA
    Arch Pathol Lab Med; 2018 Jul; 142(7):838-850. PubMed ID: 29582677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.